These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28377467)

  • 1. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound contrast agents: balancing safety versus efficacy.
    Main ML; Goldman JH; Grayburn PA
    Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
    Kalra A; Shroff GR; Erlien D; Gilbertson DT; Herzog CA
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):206-7. PubMed ID: 24524748
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
    Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML
    J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.
    Wever-Pinzon O; Suma V; Ahuja A; Romero J; Sareen N; Henry SA; De Benedetti Zunino M; Chaudhry FF; Suryadevara RS; Sherrid MV; Chaudhry FA
    Eur Heart J Cardiovasc Imaging; 2012 Oct; 13(10):857-62. PubMed ID: 22427401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CaRES (Contrast Echocardiography Registry for Safety Surveillance): a prospective multicenter study to evaluate the safety of the ultrasound contrast agent definity in clinical practice.
    Weiss RJ; Ahmad M; Villanueva F; Schmitz S; Bhat G; Hibberd MG; Main ML;
    J Am Soc Echocardiogr; 2012 Jul; 25(7):790-5. PubMed ID: 22560734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent.
    Exuzides A; Main ML; Colby C; Grayburn PA; Feinstein SB; Goldman JH
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):578-85. PubMed ID: 20541713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses.
    Wei K; Mulvagh SL; Carson L; Davidoff R; Gabriel R; Grimm RA; Wilson S; Fane L; Herzog CA; Zoghbi WA; Taylor R; Farrar M; Chaudhry FA; Porter TR; Irani W; Lang RM
    J Am Soc Echocardiogr; 2008 Nov; 21(11):1202-6. PubMed ID: 18848430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study of the occurrence of serious adverse reactions among patients who receive optison in routine medical practice.
    Wei K; Shah S; Jaber WA; DeMaria A
    J Am Soc Echocardiogr; 2014 Sep; 27(9):1006-10. PubMed ID: 24930121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound contrast agent safety: from anecdote to evidence.
    Main ML
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1057-9. PubMed ID: 19761982
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents.
    Li P; Armstrong WF; Miller DL
    Ultrasound Med Biol; 2004 Jan; 30(1):83-91. PubMed ID: 14962612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?
    Knebel F; Schimke I; Eddicks S; Walde T; Ziebig R; Schattke S; Baumann G; Borges AC
    Cardiovasc Ultrasound; 2005 Aug; 3():21. PubMed ID: 16107209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the safety and clinical utility of contrast echocardiography.
    Chai SC; Tan PJ; Tong KL
    Singapore Med J; 2020 Apr; 61(4):181-183. PubMed ID: 31820006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).
    Main ML; Ryan AC; Davis TE; Albano MP; Kusnetzky LL; Hibberd M
    Am J Cardiol; 2008 Dec; 102(12):1742-6. PubMed ID: 19064035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts.
    Parker JM; Weller MW; Feinstein LM; Adams RJ; Main ML; Grayburn PA; Cosgrove DO; Goldberg BA; Darge K; Nihoyannopoulos P; Wilson S; Monaghan M; Piscaglia F; Fowlkes B; Mathias W; Moriyasu F; Chammas MC; Greenbaum L; Feinstein SB
    Am J Cardiol; 2013 Oct; 112(7):1039-45. PubMed ID: 23816393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does contrast echocardiography with Optison induce myocardial necrosis in humans?
    Borges AC; Walde T; Reibis RK; Grohmann A; Ziebig R; Rutsch W; Schimke I; Baumann G
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1080-6. PubMed ID: 12373250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of SF6(SonoVue®) Contrast Agent on Pharmacological Stress Echocardiogram.
    Furtado RG; Rassi DDC; Melato LH; Oliveira ACR; Nunes PM; Baccelli PE; Santos SCO; Santos VE; Rassi Junior L; Nunes CG
    Arq Bras Cardiol; 2021 Dec; 117(6):1170-1178. PubMed ID: 34644784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Definity on systemic and pulmonary hemodynamics in patients.
    Wei K; Main ML; Lang RM; Klein A; Angeli S; Panetta C; Mikati I; Lee LV; Bernstein JA; Ahmad M
    J Am Soc Echocardiogr; 2012 May; 25(5):584-8. PubMed ID: 22365709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of ultrasound contrast agents in stress echocardiography.
    Gabriel RS; Smyth YM; Menon V; Klein AL; Grimm RA; Thomas JD; Sabik EM
    Am J Cardiol; 2008 Nov; 102(9):1269-72. PubMed ID: 18940305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.